【IR】Notice regarding the transfer of a consolidated subsidiary (share transfer) and the recognition of an impairment loss

At the Board of Directors meeting held on February 13th 2025, CYBERDYNE Inc. (from now on, referred to as the “Company”) resolved to transfer all of its shares on the consolidated subsidiary, LeyLine GmbH (State of NRW, Germany,; from now on referred to as “LeyLine”) according to the detail stated below.
As a result of this share transfer, LeyLine will no longer be a consolidated subsidiary of the Company.

1.  Reason for the share transfer
As a research and development-driven company, the Company promotes a wide range of highly innovative challenges. In September 2021, a strategic partnership was formed with LeyLine to expand business in the mobility field using Cybernics Technology, and in March 2023, LeyLine was made a consolidated subsidiary of Company.
Since then, efforts have been made in various initiatives to accelerate LeyLine’s business development, leading to approximately a threefold increase in the company revenue. However, sustained investment is essential for further growth, and establishing a self-sustaining profitability structure is expected to take time. Considering these circumstances, careful discussions were held by the Board of Directors regarding the optimal allocation of management resources across the group and the appropriate approach to supporting LeyLine’s future growth. As a result of a comprehensive assessment, it was concluded that transferring LeyLine’s shares and removing them from the consolidated group would be the optimal course of action.
This share transfer will enable the CYBERDYNE group to utilize management resources more efficiently, accelerate its growth strategy while improving profitability as well as allowing LeyLine to operate with greater flexibility under an independent management structure, creating opportunities for further growth.

6.  Recognition of impairment loss
In connection with this share transfer, an impairment loss of ¥175 million has been recorded as other expenses in the ‘Q3 FY2025 Financial Results [IFRS] (Consolidated)’ announced today.

pdf link